| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2010 | US20100008976 Medical Use of N-Phenylpropenoyl-Amino Acid Derivatives and Related Compounds |
| 01/14/2010 | US20100008974 Transdermal granisetron |
| 01/14/2010 | US20100008973 Compositions And Methods For Wound Healing |
| 01/14/2010 | US20100008970 Drug-Eluting Endoprosthesis |
| 01/14/2010 | US20100008968 Method for treating cardiovascular diseases using rho kinase inhibitor compounds |
| 01/14/2010 | US20100008966 Medical Devices and Methods for Delivery of Nucleic Acids |
| 01/14/2010 | US20100008956 Composition and combinations of carboxylic acid losartan in dosage forms |
| 01/14/2010 | US20100008954 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 01/14/2010 | US20100008942 Histophilus Somni Polynucleotides, Polypeptides and Methods of Use |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008935 Method for identifying therapeutical targets in tumors, the use thereof and means for determining and targeting angiogenesis and hemostasis related to andenocarcinomas of the lung |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008930 Method for the diagnosis of leukemia |
| 01/14/2010 | US20100008927 Use of (S)-Roscovitine for Prevention and/or Treatment of Neurological Diseases |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008923 Organic Compounds |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008916 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008912 Combination drug |
| 01/14/2010 | US20100008910 Methods and compositions for the diagnosis and treatment of cancer |
| 01/14/2010 | US20100008908 Treatment of Heart Failure |
| 01/14/2010 | US20100008904 administering to the subject an effective amount of an inhibitor of an acid-sensing ion channel 3, wherein the inhibitor is a polypeptide that binds to the acid-sensing ion channel 3 |
| 01/14/2010 | US20100008901 Methods for the treatment and prevention of cancer |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | US20100008896 Use of Fenretinide or Bioactive Derivatives Thereof and Pharmaceutical Compositions Comprising the Same |
| 01/14/2010 | US20100008894 Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder |
| 01/14/2010 | US20100008891 Production of Pluripotent Cells Through Inhibition of Bright/Arid3a Function |
| 01/14/2010 | US20100008887 Anti-obesity composition containing acacia bark derivative |
| 01/14/2010 | US20100008868 Sustained remission of atopic dermatitis |
| 01/14/2010 | US20100008867 Method of treatment and pharmaceutical compositions |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | US20100008865 Mixture of iron and copper salts masking metallic taste |
| 01/14/2010 | US20100008859 Methods of treatment using ammonia-scavenging drugs |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | DE10235602B4 Metallcluster-Nanoverbindungen zur Behandlung von Tumorerkrankungen Metal nano-cluster compounds for the treatment of tumor diseases |
| 01/14/2010 | DE102008045152A1 Künstliche Sauerstoffträger und ihre Verwendung Artificial oxygen carriers and their use |
| 01/14/2010 | DE102008032594A1 Transfektionslösung Transfection |
| 01/14/2010 | DE102008032327A1 Cosmetic or pharmaceutical preparation, useful for the topical application of polyunsaturated fatty acids, comprises polyunsaturated fatty acids, which are present in the form of vesicles, and a carrier system made from phospholipids |
| 01/14/2010 | CA2767331A1 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/14/2010 | CA2756053A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and antiviral, antibacterial, and anticancer agents |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730591A1 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 01/14/2010 | CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | CA2730420A1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 01/14/2010 | CA2730385A1 Treating inflammation and related conditions with irindalone |
| 01/14/2010 | CA2730377A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| 01/14/2010 | CA2730319A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730314A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730311A1 Icotinib hydrochloride, synthesis, crystalline forms, drug combinations, and uses thereof |
| 01/14/2010 | CA2730304A1 Novel compounds, use thereof as medicaments, and method for the preparation thereof |
| 01/14/2010 | CA2730302A1 Use of indole derivatives as nurr-1 activators for treating parkinson's disease |
| 01/14/2010 | CA2730280A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 01/14/2010 | CA2730274A1 Use of rifalazil to treat colonic disorders |
| 01/14/2010 | CA2730271A1 Pi3k isoform selective inhibitors |
| 01/14/2010 | CA2730270A1 Dicarba-analogues of octreotide |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730253A1 Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide |
| 01/14/2010 | CA2730251A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730231A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | CA2730211A1 Use of opioid antagonists for treating urinary retention |
| 01/14/2010 | CA2730203A1 Complement antagonists and uses thereof |
| 01/14/2010 | CA2730154A1 The application of potassium 2-(1-hydroxypentyl)-benzoate (d1-phpb) for the prevention and treatment of alzheimer's disease |
| 01/14/2010 | CA2730120A1 Method of treating blepharitis |
| 01/14/2010 | CA2730112A1 Directly pressed aliskiren tablets |
| 01/14/2010 | CA2730111A1 Synthesis of metabolically stable agents for alcohol and drug abuse |
| 01/14/2010 | CA2730110A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/14/2010 | CA2730106A1 Kinase inhibitors and methods of use |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2730085A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 01/14/2010 | CA2730083A1 Stimulus-responsive apta-chelamers |
| 01/14/2010 | CA2730079A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | CA2730074A1 Anti-phthiraptera treatment compositions |
| 01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2730065A1 Improving renal function with quercetin-containing compositions |
| 01/14/2010 | CA2730037A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | CA2730010A1 Inhibitors of janus kinases |
| 01/14/2010 | CA2730008A1 Eprosartan compositions |
| 01/14/2010 | CA2730003A1 Cyclic sulfones with aminobenzyl substitution useful as bace inhibitors |
| 01/14/2010 | CA2729988A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | CA2729985A1 Thiazolidine compounds as orexin receptor antagonists |
| 01/14/2010 | CA2729979A1 Pharmaceutical compositions comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| 01/14/2010 | CA2729974A1 Topical composition for the treatment of actinic keratosis |
| 01/14/2010 | CA2729950A1 Transdermal estrogen device and delivery |
| 01/14/2010 | CA2729948A1 Tacrolimus for improved treatment of transplant patients |
| 01/14/2010 | CA2729944A1 Antimicrobial composition |
| 01/14/2010 | CA2729943A1 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 01/14/2010 | CA2729914A1 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway |
| 01/14/2010 | CA2729896A1 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2729852A1 Hydrophobically enhanced aminoglycosides |
| 01/14/2010 | CA2729845A1 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 01/14/2010 | CA2729834A1 Formulations for treating eye disorders |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |